P3 Prostate Cancer Forum: 17th - 18th May, 2024

perspectives, possibilities, progress

P3 background - Article

The landscape of prostate cancer treatment is rapidly evolving. The P3 Forum is dedicated to offering education and diverse expert perspectives on the latest advancements in the field, providing in-depth insights into the treatment and care of patients with advanced prostate cancer.

The expert P3 panel shares valuable insights on how to effectively leverage the latest treatments to extend survival and importantly, maintain quality of life. They explore the impact of new screening protocols and next generation imaging on prostate cancer detection, staging, and treatment, and investigate the latest guidelines and how they impact clinical practice.

Featuring short videos, discussions on patient case studies, and interactive Q&A sessions, enhance your professional development now through a 4-stage prostate cancer journey.

These promotional meetings have been initiated and funded by Bayer UK and are for UK Healthcare professionals only.

Start here with an introduction from Professor Amit Bahl: Navigating the Prostate Cancer Treatment Landscape
P3 Prostate Cancer Forum Session 1 & 2
Session 1: Prostate Cancer Screening: Current Perspective
Explore valuable insights on prostate cancer screening. Our expert panel delve into the changing dynamics.
PP-NUB-GB-2013, January 2025
Session 2: Decoding mHSPC: Unravelling the complexities
Our experts share their insights on optimising treatment in mHSPC, delving specifically into triple therapy.
PP-NUB-GB-2016, January 2025
P3 Prostate Cancer Forum Session 3 & 4
Session 3: Mapping the Journey: Strategies and RWE in nmC...
We gained insights into nmCRPC patients in the UK, and discussed how the treatment paradigm is shifting.
PP-NUB-GB-2017, January 2025
Session 4: Confronting the challenges of mCRPC
we took a deep dive into mCRPC; the latest therapies, data and key considerations for treatment sequencing.
PP-NUB-GB-2019, January 2025
CO-CHAIRS
    • Phillip Cornford V4.png_
      Professor Philip Cornford

    Honorary Associate Professor

    Liverpool University Hospitals NHS Foundation Trust

    Chair of EAU Prostate Cancer Guidelines Panel

    • Heather Payne
      Professor Heather Payne

    Honorary Consultant Clinical Oncologist

    University College Hospital, London

    Clinical Director of the Prostate Centre, London

SPEAKERS
    • Professor Alison Birtle
      Professor Alison Birtle

    Consultant Clinical Oncologist

    MAHSC Honorary Clinical Professor  in the Faculty of Biology, Medicine & Health at the University of Manchester, and Honorary Clinical Professor at The University of Central Lancashire

    • Caroline Moore
      Professor Caroline Moore
      Professor of Urology at University College London in the Department of Targeted Intervention
    • Matthew Hobbs
      Dr Matthew Hobbs
      Director of Research, Prostate Cancer UK
    • Dr Masood
      Dr Masood Moghul
      Post-CCT Urologist, PhD Student Royal Marsden Hospital and Institute of Cancer Research
    • Alison Tree
      Dr Alison Tree
      Consultant clinical oncologist at The Royal Marsden
    • Mark Lich
      Dr Mark Linch
      Consultant medical oncologist, Honorary senior lecturer at University College London (UCL) Cancer Institute
    • Doraid
      Dr Doraid Alrifai
      Consultant medical oncologist at St George’s University Hospital NHS Foundation Trust
    • Dr Andrew
      Professor Andrew Protheroe
      Medical Oncologist within the University of Oxford department of Oncology at the Oxford Cancer and Haematology Centre
    • Mark Prentice
      Dr Mark Prentice
      Consultant Clinical Oncologist Royal Free Hospital NHS Foundation Trust
    • Dr Fayiza
      Ms Fayiza Habeeb
      Lead Nurse Practioner Royal Free Hospital London
    • Bill Cross
      Mr Bill Cross
      Consultant Urologist Leeds Teaching Hospital Trust
    • Asad
      Mr Asad Abedin
      Consultant Urological Surgeon at the Dudley Group NHS Foundation Trust
    • Georgia Malesi
      Ms Georgia Malesi
      Principal Pharmacist for Cancer Services at the Dudley Group of Hospitals
    • Mark B
      Dr Mark Beresford
      Consultant Clinical Oncologist, Royal United Hospital Bath, Honorary Senior Lecturer at Bristol University, Visiting Researcher at Bath University
    • Mike Osborn
      Dr Mike Osborn
      Clinical Psychologist, , Royal United Hospital Bath
    • Paula Al
      Ms Paula Allchorne
      Urology Lead Nurse Barts Health NHS Trust, Psychosexual Nurse Specialist and Relationship Therapist
    • Vineetha Thankappan Nair
      Ms Vineetha Thankappan Nair
      Macmillan Lead Clinical Nurse Specialist
    • Kieran O
      Mr Kieran O’Flynn
      Consultant Urologist, Salford Royal Foundation Trust
    • Robert Jones
      Professor Robert Jones
      Clinical Cancer Research at the University of Glasgow and a Consultant at the Beatson West of Scotland Cancer Centre
    • Dr Elena Castro
      Dr Elena Castro
      Consultant Medical Oncologist, Virgen de la Victoria University Hospital in Malaga, Spain
Are you interested in P3 2025?

Register your interest to attend either virtually or in-person for 2025's meeting.

P3 Prostate Cancer Forum 2024 - Meeting Summary
PP-NUB-GB-2020, January 2025

PP-NUB-GB-2012 | January 2025